Cell and Gene Therapy


We work with our clients to design facilities with a high level of flexibility to support emerging product pipelines. We rely on our decades of experience in cell culture, single-use systems, and process design to deliver advanced-therapy medicinal product facilities. These facilities support our clients' clinical and commercial production capabilities for their long-term goals as well as protect against significant capital investment to reconfigure. Our designs have worked with both stick built build-outs of existing spaces and iCON delivery approaches.
Cell and Gene Therapy Specialties
-
COVID-19
Learn MoreAs the world tackles the pandemic and tries to create a sense of normalcy during these unprecedented times, we continue to work in excellence with our clients to deliver fast-track solutions to the pandemic.
-
Therapeutic Proteins
Learn MoreUsing our expertise at the cellular level of biotechnology, we plan and engineer areas for our clients to manipulate DNA and gain maximum value from their research.
-
Vaccines
Learn MoreWe deliver compliant solutions for our clients’ vaccine needs. From formulation to serialization, we speed time to market.
Antibody Drug Conjugates
We use our expertise in ADC and mAb manufacturing to produce facilities from start-up to large-scale commercial.
We have the knowledge to create CGMP compliant and scaleable facilities. We have designed facilities to seed, scale up, harvest and purify cell culture products that utilize 100% single-use systems, up to the 20,000L scale.
Featured Cell and Gene Therapy Experts
-
Thomas J. Piombino
Managing Director, Americas
-
Mark E. Rezac, PE
Director, Compliance Services
-
Alicia Riesgo
NJ Regional Director, Compliance Services
-
Tim Schuster
Director, Process Engineering
-
Michael Westerman
Sr. Director, CQV Operations